Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1995
12/26/1995US5478938 Antagonists for angiotensin II receptors; hypotensive, cardiotonic agents; cognitive activators
12/26/1995US5478937 Chemical intermediates for antiarrhythmia agent, antilipemic agent, vasodilator and hypotensive agent
12/26/1995US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors
12/26/1995US5478856 Styrene derivatives and salts thereof
12/26/1995US5478852 Administering
12/26/1995US5478845 Piperidine derivatives
12/26/1995US5478844 Method of using aminocoumaran derivatives for treating cerebrovascular diseases
12/26/1995US5478836 Treaing hypertension, atheroschlerosis
12/26/1995US5478835 Tricyclic compounds and intermediates thereof
12/26/1995US5478831 R-(-)1-(5-hydroxyhexyl)-3-methyl-7-propylxanthine, a process for its preparation and pharmaceuticals containing this compound
12/26/1995US5478822 Antiallergens, antiinflammatory, cardiovascular agents
12/26/1995US5478821 Method of accelerating the proliferation of emdothelial cells with inhibition of no synthases
12/26/1995US5478817 Treatment of hypertension, heart failure
12/26/1995US5478807 Increases rate of stimulus provided by subsidiary pacemakers
12/26/1995US5478573 Delayed, sustained-release propranolol pharmaceutical preparation
12/25/1995CA2152432A1 Use of a lactam compound as pharmaceutically active ingredient
12/22/1995WO1994028924A1 Combination of angiotensin converting enzyme inhibitors and aii antagonists
12/22/1995CA2165410A1 Combination of angiotensin converting enzyme inhibitors and all antagonists
12/21/1995WO1995034651A2 Corticotropin-releasing factor2 receptors
12/21/1995WO1995034564A1 Pirydyl imidazole derivatives and processes for the preparation thereof
12/21/1995WO1995034561A1 Benzoylecgonine, ecgonine and ecgonidine derivatives
12/21/1995WO1995034556A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
12/21/1995WO1995034555A1 Benzimidazolone derivatives with central dopaminergic activity
12/21/1995WO1995034545A1 Benzopyrans and their use as therapeutic agents
12/21/1995WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
12/21/1995WO1995034539A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption
12/21/1995WO1995034534A1 Enzyme inhibitors
12/21/1995WO1995034324A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995WO1995034304A1 Pharmacologically active 2-mercaptobenzimidazole derivatives
12/21/1995WO1995018616A3 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor
12/21/1995CA2193072A1 Corticotropin-releasing factor2 receptors
12/21/1995CA2192668A1 Amidino sulfone derivatives for use as inos inhibitors claims
12/21/1995CA2192460A1 Cyclobut-3-ene-1,2-dione derivatives as smooth muscle relaxants
12/21/1995CA2192459A1 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption
12/21/1995CA2191870A1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
12/21/1995CA2190611A1 Covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives
12/21/1995CA2152030A1 Heterocyclyloxybenzoylguanidines
12/20/1995EP0687911A2 Methods for assaying endotoxin concentration
12/20/1995EP0687472A2 Potentiation of drug response by a serotonin 1A receptor antagonist
12/20/1995EP0687469A2 Anti-arrhythmic 3,7-diazabicyclo (3,3,1)nonane compounds
12/20/1995EP0687411A1 Hepatic graft preservative composition and a method for viable preservation of the hepatic graft
12/20/1995EP0687264A1 Method for preparing n-methyl 2-(3-pyridyl) (1r,2r)-2-tetrahydrothiopyrancarbothioamide-1-oxide
12/20/1995EP0687256A1 Hydroxymethyl furazane carboxylic acid derivatives and their use in the treatment of cardio-vascular conditions
12/20/1995EP0687253A1 New 4-aminopyridines, process for preparing the same and medicaments containing the same
12/20/1995EP0687252A1 2-phenoxyethylamine derivatives, their preparation and their therapeutical use
12/20/1995EP0687251A1 1,3-dihydroindol-2-one derivatives substituted in position 3 by a nitrogen group as vasopressin and/or ocytocine agonists and/or antagonists
12/20/1995EP0687249A1 Balanoids
12/20/1995EP0687178A1 Use of 2h-1,2,4-benzothiadiazine 3(4h)-one 1,1 dioxide derivatives as non-competitive nmda receptor antagonists
12/20/1995EP0435902B1 2-hydroxy-3-phenoxy-propyl-substituted piperazines, their manufacture and use
12/20/1995EP0290496B2 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery
12/20/1995CN1113487A Method for preparing pharmaceutically active CNS compounds
12/20/1995CN1113485A Process for the production of medicaments containing substituted pyridyl-dihydroxy-heptenonic acid or its salts
12/20/1995CN1113437A A process for preparing a pharmaceutical composition containing benzothiazole compounds
12/20/1995CN1113436A Potentiation of drug response
12/20/1995CN1113435A Preparation of pharmaceutical composition containing novel thiazolidone and oxazolidone
12/20/1995CN1113434A Drug
12/19/1995US5476857 Imidazopyridines
12/19/1995US5476856 Treatment of PAF and histamine-mediated diseases with 8-chloro-11-[1-[(5-methyl-3-pyridyl)methyl]-4-piperidyliden]-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
12/19/1995US5476851 Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase
12/19/1995US5476850 Amino-substituted benzenesulfonylureas and -thioureas and their use as pharmaceuticals
12/19/1995US5476847 Treating cardiovascular, gastrointestinal, urogenital disorders
12/19/1995US5476846 Administering anti-thrombotic and anti-asthmatic agent
12/19/1995US5476840 Hypotensive agents
12/19/1995CA1337767C Indolocarbazole derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
12/19/1995CA1337764C 1,4-dihydropyridine derivatives and pharmaceutical composition thereof
12/18/1995CA2152118A1 Pharmaceutical compositions containing 3,7-diazabicyclo[3,3,1]nonane compounds and use thereof for treating supraventricular arrhythmias
12/15/1995CA2151750A1 Hepatic graft preservative composition and a method for viable preservation of the hepatic graft
12/14/1995WO1995033840A1 Recombinant viruses, preparation and use thereof in gene therapy
12/14/1995WO1995033752A1 Endothelin receptor antagonists
12/14/1995WO1995033748A1 Endothelin receptor antagonists
12/14/1995WO1995033747A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents
12/14/1995WO1995033744A1 Tachykinin (nk1) receptor antagonists
12/14/1995WO1995033729A1 Serotonin 5-ht1a and dopamin d2 receptor ligands
12/14/1995WO1995033723A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and thiomorpholines as calcium channel antagonists
12/14/1995WO1995033722A1 Phenoxyalkyl substituted piperidines, pyrrolidines, morpholines and tiomorpholines as calcium channel antagonists
12/14/1995WO1995033721A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
12/14/1995WO1995033709A1 Hydroxylamine derivatives and their use as metalloproteinase inhibiting agents
12/14/1995WO1995033495A1 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
12/14/1995WO1995033486A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
12/14/1995WO1995033484A1 Method for treating and preventing atherosclerosis
12/14/1995WO1995033461A1 Anti-inflammatory compounds
12/14/1995WO1995028426A3 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
12/14/1995WO1995026325A3 Enhancement of the efficacy of drugs by deuteration
12/14/1995CA2192113A1 Serotonin 5-ht 1a and dopamin d2 receptor ligands
12/14/1995CA2192112A1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
12/14/1995CA2190128A1 Novel 1,1-bis(heteroazolyl)alkane derivatives and their use as neuroprotective agents
12/14/1995CA2187531A1 Tachykinin (nk1) receptor antagonists
12/13/1995EP0686642A2 Modified guanidino and amidino thrombin inhibitors
12/13/1995EP0686629A2 Cyclohexyl tachykinine receptor antagonists
12/13/1995EP0686627A2 Substituted perfluoroalkylguanidines, process for their preparation, their use as medicine or diagnostic as well as medicines containing them
12/13/1995EP0686395A2 Use of hyaluronic acid for the manufacture of a medicament for the inhibition of platelet aggregation
12/13/1995EP0686394A1 Use of N-[[5-(naphthales-1-yl)-1,3-dioxan-2-yl]alkyl]acetamide derivatives for the preparation of medicaments for use in the treatment of neurodegenerative disorders
12/13/1995EP0686144A1 New compounds
12/13/1995EP0686044A1 Inhibition of intimal hyperplasia using antibodies to pdgf receptors
12/13/1995EP0573473B1 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
12/13/1995CN1113235A Benzimidazoles, pharmaceutical compositions containing these compounds and processes for preparing them
12/13/1995CN1113154A Rehabilitation pill for brains and its production technology
12/12/1995US5475113 Tetrahydronaphthyl and thiazole, oxazole or imidazole substituted ethene derivatives having retinoid-like activity, reduced skin toxicity and reduced teratogenecity
12/12/1995US5475032 Treating strokes
12/12/1995US5475016 Sulphonylbenzyl-substituted imidazolypropenoic acid derivatives
1 ... 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 ... 1595